Moli, Neta T.
HRN: 14-89-35 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/13/2025
CEFTAZIDIME 1GM (VIAL)
02/13/2025
02/19/2025
IV
2G
Q8h
CAM PR
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes